Background Recent studies indicate that bladder cancer is among the top 10 most common
cancers in the world (Saginala et al. 2022). Bladder cancer frequently reoccurs, and …

Bladder cancer (BC) is one of the top 10 most common tumours worldwide; however, no
molecular markers are currently available for tumour management and follow-up. BC could …

Quinolones, broad-spectrum antibiotics, are frequently prescribed by urologists for many
urological disorders. The mechanism of their bactericidal activity is based on the inhibition of …

Background High recurrence and progression rates are major clinical challenges for non–
muscle-invasive bladder cancer (NMIBC). Dietary isothiocyanates (ITCs), phytochemicals …

Epirubicin, gemcitabine, and pirarubicin are widely used as first‐line drugs for intravesical
chemotherapy to prevent tumor recurrence after transurethral bladder tumor resection for …

Bladder cancer is a prevalent disease, and treatment options for advanced bladder cancer
remain limited. However, immune checkpoint inhibitors (ICIs) targeting cytotoxic T …

Background There is increasing evidence of associations between residential proximity to
livestock farms and respiratory morbidity, but less is known about potential effects on …

Objective To investigate the accuracy of Vesical Imaging-Reporting and Data System (VI-
RADS) in detection of muscle-invasive bladder cancer (MIBC) we performed a systematic …

Simple Summary Radiotherapy with curative intent in the treatment of metastatic
malignancies has shown promising results in several types of primary tumors but experience …

Non-muscle invasive bladder cancer (NMIBC) accounts for~ 70–75% of total bladder cancer
tumors and requires effective early intervention to avert progression. The cornerstone of high …